Navigation Links
Gene signal GS-101 data shows safe and effective inhibition of ophthalmic blood vessel growth
Date:9/1/2009

Lausanne, Switzerland Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of interim results from a phase II study suggesting that the antisense oligonucleotide GS-101 (eye drops) is safe and effective at inhibiting and regressing corneal neovascularisation (abnormal new blood vessel growth). Neovascularisation in this part of the eye is a major risk factor in corneal graft rejection, the most common transplantation procedure that saves the sight of approximately 46,000 people worldwide each year.

The data were published in the September 2009 issue of Ophthalmology by researchers led by Claus Cursiefen, MD, from the Department of Ophthalmology at the Friedrich-Alexander University Erlangen-Nrnberg, in Erlangen, Germany. Gene Signal is now conducting an international phase III trial with GS-101 for the prevention of pathologic corneal neovascularisation and thereby corneal graft rejection. GS-101 has been granted Orphan Drug status for this indication in Europe.

"Compared to the placebo group in which 100% of patients suffered from progression of corneal neovascularisation, the optimal GS-101 treatment group showed regression in 86% of patients. We are very encouraged by these results as they represent real progress in the development of GS-101 as a new treatment to combat corneal graft rejection," explained Dr. Claus Cursiefen of the Department of Ophthalmology, Friedrich-Alexander University Erlangen-Nrnberg. "We urgently need new options for the thousands of graft recipients, whose current treatment options for threatened rejection such as immunosuppressants are not ideal due to side effects. GS-101 is the first specific angiogenesis inhibitor that has demonstrated activity at the anterior part of the eye, where numerous diseases associated with pathologic angiogenesis endanger vision."

"The publication of these positive phase II results for G
'/>"/>

Contact: Mike Sinclair
msinclair@halsin.com
44-200-845-955
Halsin Partners
Source:Eurekalert

2

GOOD

Page: 1 2 3

Related biology news :

1. Scientists find clue to mechanisms of gene signaling and regulation
2. Study finds blocking angiogenesis signaling from inside cell may lead to serious health problems
3. Researchers find signal that switches on eye development -- could lead to eye in a dish
4. Cell response to stress signals predicts tumors in women with common pre-breast cancer
5. Rong Li Lab reports protein interactions of MAP kinase signaling pathway
6. DNA variations signal lupus risk
7. Newly defined signaling pathway could mean better biofuel sources
8. Statistics are insufficient for study of proteins signal system
9. Science expands Science Signaling, featuring research related to medical advances, and more
10. Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia
11. Presence of certain antibodies signals healthier teeth and gums
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2010)... health habits or behaviors, like cigarette smoking, may influence ... against HPV. , According to survey results on ... to vaccinate their daughters was not associated with one,s ... with certain behavioral factors of the parents. , Results ... of Cancer Epidemiology, Biomarkers & Prevention , a ...
(Date:2/7/2010)... per week increased the risk of developing pancreatic cancer ... consume soft drinks, according to a report in ... the American Association for Cancer Research. , Although ... deadly, and only 5 percent of people who are ... Ph.D., senior author on the study and associate professor ...
(Date:2/7/2010)... PAUL, Minn. Workers exposed to tricholorethylene (TCE), a ... auto parts, may be at a significantly higher risk ... today that will be presented at the American Academy ... to April 17, 2010. , "This is the first ... exposure to TCE may increase a person,s risk of ...
Breaking Biology News(10 mins):More smokers than non-smokers accept HPV vaccination for their daughters 2More smokers than non-smokers accept HPV vaccination for their daughters 3Soft drink consumption may increase risk of pancreatic cancer 2Elephant size loopholes sustain Thai ivory trade 8912 1Elephant size loopholes sustain Thai ivory trade 8912 2Hospira Receives Favorable Court Decision on Eloxatin 28R 29 12701 1Hospira Receives Favorable Court Decision on Eloxatin 28R 29 12701 2Hospira Receives Favorable Court Decision on Eloxatin 28R 29 12701 3K State Veterinarian Says Although Exotic Pets Can Be Great Companions There Are Health Factors That Can Affect Both the Animal and Humans 49435 1K State Veterinarian Says Although Exotic Pets Can Be Great Companions There Are Health Factors That Can Affect Both the Animal and Humans 49435 2K State Veterinarian Says Although Exotic Pets Can Be Great Companions There Are Health Factors That Can Affect Both the Animal and Humans 49435 3
... MADISON, WI, OCTOBER 20, 2008 -- The widespread use of ... decades, with little knowledge of the long-term effects on the ... study show that samples taken from over 300 wells across ... contamination. The news is a result of a decadal long ...
... Fritz et al. have identified an amino acid switch ... such as tick-borne encephalitis virus (TBEV), yellow fever, and ... cells by being gobbled up into endosomes and fusing ... triggered by the endosome,s acidic environment. Low pH prompts ...
... -- Researchers are one step closer to finding a ... for TB tested at Saint Louis University appears likely ... disease than the one in current use. , "Not ... it induced a better immune response, which suggests it ...
Other Biology News:Pesticide concentrations decreasing 2Research identifies type of vaccine that holds promise in protecting against TB 2
(Date:2/8/2010)... months ahead of schedule ,, TSX Exchange Symbol: RVX ... Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today the ... study of its lead drug RVX-208. "The completion of ... 5 months ahead of our original schedule, is a ... at the Cleveland Clinic. At this rate we could ...
(Date:2/8/2010)... clinical services team to present the critical processes that comprise ... departments. , ... Chicago, IL (PRWEB) ... Trial Operations (CTO) software, today announced that both Kristin Lucas ... selected to speak at the CBI Forecasting & Budgeting conference ...
(Date:2/8/2010)... SAN DIEGO , Feb. 8 ... that it has appointed William H. Rastetter Ph.D. to ... current Chairman and Chief Executive Officer of Receptos, Inc., ... "We are very pleased to welcome Bill Rastetter ... A. Mollica , Ph.D., Chairman of the Board of ...
(Date:2/8/2010)... is pleased to announce that it has hired Lisa Wichman and Sahar ... joins HDS as an Account Manager and will focus on key healthcare ... the Manager of that group Omaha, NE. , ... Foothill Ranch, CA ... pleased to announce the hiring of a new Account Manager and Manager ...
Breaking Biology Technology:Resverlogix Completes Patient Recruitment for ASSERT Trial 2Resverlogix Completes Patient Recruitment for ASSERT Trial 3Resverlogix Completes Patient Recruitment for ASSERT Trial 4ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 2ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 3ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 4Neurocrine Biosciences Announces the Appointment of William H. Rastetter to Its Board of Directors 2Healthcare Data Solutions Announces Expansion of its Healthcare Customer Solutions Team With Two Key Additions 2Healthcare Data Solutions Announces Expansion of its Healthcare Customer Solutions Team With Two Key Additions 3
... 4 Imaging Diagnostic,Systems, Inc., (OTC Bulletin Board: IMDS), ... a new study evaluating the CTLM system as an,adjunct ... of Academic,Radiology. , ... Alexander Poellinger, MD, a radiologist at Charite Hospital in ...
... HARLEYSVILLE, Pa., Dec. 4 Raymond J. De Hont, Chairman and ... today that the Company,s Board of Directors, at their meeting on ... payable on March 12, 2009 to shareholders of record at the ... a 9.1% increase over the same period last year. , ...
... Pharma Limited ("Azur") today,announced that it has entered ... BPAX ) to acquire U.S. rights ... of estradiol which is,indicated for the treatment of ... was approved by the U.S. Food and Drug,Administration ...
Other Biology Technology:Imaging Diagnostic Systems CT Laser Mammography (CTLM) Technology Featured in Peer-Reviewed Journal 2Met-Pro Corporation Declares Quarterly Dividend 2Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM) 2
... (Dual-Stage Quadrupole) Thermo Scientific (Part of Thermo ... instrumentation, introduces the latest product innovation for ... on the proven reliability and performance platform ... the DSQ II incorporates the new DynaMax ...
... Library Panels were designed for full-length gene ... PCRs to identify the desired cDNA clone. ... a 96-well "Master Plate," where each well ... identified the positive well(s) by gel electrophoresis ...
... The ProteoSpin CBED Micro Kit provides a ... exchange and desalting of protein samples. The ... Norgens patented protein resin as an ion ... CaCl2,LiCl, CsCl have poor affinities for Norgens ...
... Pathway 435 is an affordable, compact ... and slides, providing a broad array ... rapidly acquires high-resolution images with high-performance ... computer-controlled excitation and emission filter changers, ...
Biology Products: